author-photo

Mark S. Shaefer

Research Triangle Park

47

Papers

1440

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

To dose-adjust or not to dose-adjust: 3TC dose in kidney impairment.

2021 AIDS
Show All
- Source
- Cite
- Save
Citations (1)
New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals

2020 Human Immunology
Show All
- Source
- Cite
- Save
Citations (9)
I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain.

2020 Culture, Health & Sexuality
Show All
- Source
- Cite
- Save
Citations (6)
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study

2020 The Lancet
Show All
- Source
- Cite
- Save
Citations (32)
Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir

2019 Journal of NeuroVirology
Show All
- Source
- Cite
- Save
Citations (1)
Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure

2019 Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (9)
2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences

2019 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (4)
Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min

2019 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (0)
Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States

2018 AIDS Research and Human Retroviruses
Show All
- Source
- Cite
- Save
Citations (5)
Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States

2018 AIDS Research and Human Retroviruses
Show All
- Source
- Cite
- Save
Citations (13)